Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Viseven, a digital transformation partner for life sciences, has just launched Lexi, an AI-powered coordinator for smarter event engagement. It was developed to help life sciences, pharma & medtech teams foster impactful engagement with attendees at life sciences events, analyze data, extract actionable insights, and personalize interactions – all in one place, while staying compliant […]
After years of shaping digital excellence in Life Sciences, eWizard and Viseven web presences now come under one roof. As an end-to-end digital commercialization partner for life sciences, Viseven naturally includes eWizard as part of its extensive portfolio of services, and this will now be reflected in the web presence of the two brands. One […]
“Are you unbiased?” It’s a fair question after reading a title like this. The honest answer is not completely. We built eWizard, an AI-powered content supply chain platform, so we naturally have firsthand experience with the challenges pharma teams face and the capabilities that help solve them. That said, this article is not intended to […]
A groundbreaking drug is ready to change lives, but regulatory hurdles, soaring R&D costs, and pricing pressures stand in the way of its success. For the pharmaceutical industry, this scenario is the reality of 2026. With a global talent shortage, aging populations driving up healthcare demands, and supply chains still recovering from recent and ongoing […]
For years, pharma influence was relatively easy to recognize. It lived in congress halls, advisory boards, journal publications, and the voices of respected clinical experts. If a physician, researcher, or professor shaped how others understood a therapy area, they were likely part of the KOL conversation. That model still matters. But it no longer covers […]
